Meg Bouvier Medical Writing is pleased to announce that our client has been awarded a seven-year Cooperative Agreement from the National Institutes of Health (NIH). The team, working at four participating medical centers, will conduct clinical trials to accelerate the discovery of treatments for critically ill patients. The work will be conducted as part of a highly prestigious, multidisciplinary clinical research consortium at NIH. While the size of the award will depend on the clinical protocols chosen, a typical seven-year clinical trial award runs in the tens of millions of dollars. Dr. Bouvier was the lead writer, editor, and advisor on the U01 submission team from Meg Bouvier Medical Writing.
This month the NIH celebrates the 10th anniversary of the NIH Common Fund, a funding mechanism created to support cross-cutting, trans-NIH programs that require participation by at least two NIH Institutes or Centers (ICs). These large collaborative, multi-disciplinary research projects often have the potential to encourage the development of innovative technologies and research tools that, until the development of the Common Fund, would have had difficulty meshing with the plans of any single one of the existing 27 NIH Institutes or Centers.
To celebrate this significant milestone in the program’s history, on July 19th the NIH hosted the Common Fund Symposium featuring talks by Dr. Zerhouni, former director of the NIH (2002-2008), as well as many of the remarkable scientists who have led research projects supported by the NIH Common Fund. For those unable to attend the symposium, an archived version of the webcast is accessible to the public here. In addition, over the course of the Symposium, the winners of the first-ever Common Fund video competition were unveiled. This competition encouraged researchers to describe their work to the public utilizing wonderfully creative and often humorous methods, and are well worth a look!
A new study in the Proceedings of the National Academy of Sciences indicates that most retractions in the biomedical and life sciences literature result from misconduct, and not “honest error” as has been reported by others. Such studies have followed a publication in the journal Nature last year indicating that retractions have risen ten-fold in the past decade. The New York Times reported on the PNAS paper on Oct 1.
Login
Log in below to access your courses.
Forgot Password
Enter your email address or username and we’ll send you instructions to reset your password.